These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 11115442

  • 21. Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.
    Cazzola M, Califano C, Di Perna F, D'Amato M, Terzano C, Matera MG, D'Amato G, Marsico SA.
    Respir Med; 2002 Oct; 96(10):790-5. PubMed ID: 12412978
    [Abstract] [Full Text] [Related]

  • 22. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [Abstract] [Full Text] [Related]

  • 23. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Jun; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 24. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS, Custovic A, Lowe LA, Aldington S, Williams M, Beasley R, Woodcock A.
    Allergy Asthma Proc; 2010 Jun; 31(5):415-21. PubMed ID: 20929609
    [Abstract] [Full Text] [Related]

  • 25. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [Abstract] [Full Text] [Related]

  • 26. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 27. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
    Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.
    Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
    [Abstract] [Full Text] [Related]

  • 28. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, Ventresca GP.
    Eur J Clin Pharmacol; 2001 Sep; 56(11):781-91. PubMed ID: 11294367
    [Abstract] [Full Text] [Related]

  • 29. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Sep; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):332-8. PubMed ID: 18511702
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.
    Cazzola M, Santus P, Di Marco F, Boveri B, Castagna F, Carlucci P, Matera MG, Centanni S.
    Respir Med; 2003 May 15; 97(5):453-7. PubMed ID: 12735659
    [Abstract] [Full Text] [Related]

  • 35. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
    Adachi M, Aizawa H, Ishihara K, Ohta K, Sano Y, Taniguchi H, Nakashima M.
    Respir Med; 2008 Jul 15; 102(7):1055-64. PubMed ID: 18394875
    [Abstract] [Full Text] [Related]

  • 36. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
    Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators.
    Am J Respir Crit Care Med; 2008 Jan 01; 177(1):19-26. PubMed ID: 17916806
    [Abstract] [Full Text] [Related]

  • 37. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
    Pediatr Pulmonol; 2000 Aug 01; 30(2):97-105. PubMed ID: 10922131
    [Abstract] [Full Text] [Related]

  • 38. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun 01; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 39. Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma.
    Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandström T, Lindberg A, Lundbäck B, Djukanović R, Holgate S, Wilson S.
    J Allergy Clin Immunol; 2003 Jul 01; 112(1):72-8. PubMed ID: 12847482
    [Abstract] [Full Text] [Related]

  • 40. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Nov 01; 56(5):494-500. PubMed ID: 14651722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.